Sort
51,593 grants matching “hepatitis”
Mechanism of Hepatitis E Virus Replication and Pathogenesis
$390,965Xiang-Jin Meng · Virginia Polytechnic Inst And St Univ · R01 · FY2009 · AI
Roles for microRNA-122 in hepatitis C virus RNA amplification
$390,924Peter Sarnow · Stanford University · R01 · FY2011 · AI
Modulation of the liver-brain axis by alcohol and its impact on Alzheimers disease pathology
$390,918Derick S Han · Keck Graduate Inst Of Applied Life Scis · R01 · FY2021 · AG
Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck
$390,906Joshua Labaer · Arizona State University-Tempe Campus · R33 · FY2023 · CA
Mechanistic insights into the crosstalk between iron metabolism and diabetes
$390,875Peijian He · Emory University · R01 · FY2021 · DK
THE ENDOTHELIAL PPARy-RXR TRANSCRIPTIONAL COMPLEX IN THE CONTROL OF METABOLISM
$390,847Jorge Plutzky · Brigham And Women'S Hospital · P01 · FY2013 · HL
Development of two simple and robust point-of-care assays for detection and therapy monitoring of hepatitis B in resource-limited settings
$390,846Helen H Lee · Diagnostics For The Real World, Ltd · R44 · FY2018 · AI
Apolipoprotein A-V: A Functional Proteomics Study
$390,844Robert O'Mara Ryan · Children'S Hospital & Res Ctr At Oakland · R01 · FY2006 · HL
Molecular Virology Core
$390,829Weidong Xiao · Indiana University Indianapolis · P01 · FY2022 · HL
Novel noncanonical actions of CAR in human Liver
$390,827Hongbing Wang · University Of Maryland Baltimore · R01 · FY2022 · CA
Strategies to improve outcomes for TNBC patients that integrate subtype-specific genomic and immune-based discoveries
$390,826Jennifer A Pietenpol · Vanderbilt University Medical Center · P50 · FY2021 · CA
Role of gammaHV68 M1 antigen in Vbeta4+ T cell expansion and fibrosis
$390,823Samuel H Speck · Emory University · R01 · FY2010 · AI
INTERLEUKIN 2 IMMUNOTHERAPY FOR HCV INFECTION
$390,814Weill Medical College Of Cornell Univ · U01 · FY2002 · AI
ACCELERATING THE PREVENTION AND CONTROL OF HIV/AIDS, VIRAL HEPATITIS, STD AND TB
$390,795Elizabeth Ponausuia · American Samoa Department Of Health · U52 · FY2013 · PS
Drug Reduction Intervention for Needle Exchange Clients
$390,790Brown University · R01 · FY2001 · DA
Regulation of memory CD8 T cell development
$390,785Susan M Kaech · Yale University · R37 · FY2013 · AI
Apo B Translocation and Degradation
$390,784San Diego State University · R01 · FY2004 · HL
Using the VACS Index to track health outcomes associated with changes in drug use
$390,775David Fiellin · Yale University · R01 · FY2015 · DA
Role of gammaHV68 M1 antigen in Vbeta4+ T cell expansion and fibrosis
$390,755Samuel H Speck · Emory University · R01 · FY2012 · AI
Glutaminase in Arterial Injury and Disease
$390,685William Durante · University Of Missouri-Columbia · R01 · FY2023 · HL
Glutaminase in Arterial Injury and Disease
$390,685William Durante · University Of Missouri-Columbia · R01 · FY2022 · HL
Glutaminase in Arterial Injury and Disease
$390,685William Durante · University Of Missouri-Columbia · R01 · FY2021 · HL
Glutaminase in Arterial Injury and Disease
$390,685William Durante · University Of Missouri-Columbia · R01 · FY2024 · HL
Molecular Pharmacology of Insulin Resistance in Burns
$390,682Jeevendra Martyn · Massachusetts General Hospital · R01 · FY2008 · GM
Protective role of creb-binding protein in maturation and aging
$390,650Charles V. Mobbs · Icahn School Of Medicine At Mount Sinai · R01 · FY2011 · HD